These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35862109)

  • 1. Effect of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization.
    Ono M; Serruys PW; Garg S; Kawashima H; Gao C; Hara H; Lunardi M; Wang R; O'Leary N; Wykrzykowska JJ; Piek JJ; Mack MJ; Holmes DR; Morice MC; Kappetein AP; Thuijs DJFM; Noack T; Mohr FW; Davierwala PM; Spertus JA; Cohen DJ; Onuma Y;
    Circulation; 2022 Oct; 146(17):1268-1280. PubMed ID: 35862109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study.
    Takahashi K; Serruys PW; Gao C; Ono M; Wang R; Thuijs DJFM; Mack MJ; Curzen N; Mohr FW; Davierwala P; Milojevic M; Wykrzykowska JJ; de Winter RJ; Sharif F; Onuma Y; Head SJ; Kappetein AP; Morice MC; Holmes DR;
    Circulation; 2021 Jul; 144(2):96-109. PubMed ID: 34011163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.
    Thuijs DJFM; Kappetein AP; Serruys PW; Mohr FW; Morice MC; Mack MJ; Holmes DR; Curzen N; Davierwala P; Noack T; Milojevic M; Dawkins KD; da Costa BR; Jüni P; Head SJ;
    Lancet; 2019 Oct; 394(10206):1325-1334. PubMed ID: 31488373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
    Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification.
    Kawashima H; Serruys PW; Hara H; Ono M; Gao C; Wang R; Garg S; Sharif F; de Winter RJ; Mack MJ; Holmes DR; Morice MC; Kappetein AP; Thuijs DJFM; Milojevic M; Noack T; Mohr FW; Davierwala PM; Onuma Y;
    JACC Cardiovasc Interv; 2022 Jan; 15(2):193-204. PubMed ID: 34973904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Choi JW; Ruzyllo W; Religa G; Huang J; Roy K; Dawkins KD; Mohr F
    Circulation; 2014 Jun; 129(23):2388-94. PubMed ID: 24700706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.
    Abdallah MS; Wang K; Magnuson EA; Osnabrugge RL; Kappetein AP; Morice MC; Mohr FA; Serruys PW; Cohen DJ;
    J Am Coll Cardiol; 2017 Apr; 69(16):2039-2050. PubMed ID: 28427580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Effect of the SYNTAX Score on 10-Year Outcomes After Left Main Coronary Artery Revascularization in a Randomized Population: Insights From the Extended PRECOMBAT Trial.
    Lee J; Ahn JM; Kim JH; Jeong YJ; Hyun J; Yang Y; Lee JS; Park H; Kang DY; Lee PH; Park DW; Park SJ;
    J Am Heart Assoc; 2021 Jul; 10(14):e020359. PubMed ID: 34227392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 10-Year Follow-Up After Revascularization in Elderly Patients With Complex Coronary Artery Disease.
    Ono M; Serruys PW; Hara H; Kawashima H; Gao C; Wang R; Takahashi K; O'Leary N; Wykrzykowska JJ; Sharif F; Piek JJ; Garg S; Mack MJ; Holmes DR; Morice MC; Head SJ; Kappetein AP; Thuijs DJFM; Noack T; Davierwala PM; Mohr FW; Cohen DJ; Onuma Y;
    J Am Coll Cardiol; 2021 Jun; 77(22):2761-2773. PubMed ID: 34082905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions.
    Kawashima H; Takahashi K; Ono M; Hara H; Wang R; Gao C; Sharif F; Mack MJ; Holmes DR; Morice MC; Head SJ; Kappetein AP; Thuijs DJFM; Milojevic M; Noack T; Mohr FW; Davierwala PM; Serruys PW; Onuma Y;
    J Am Coll Cardiol; 2021 Feb; 77(5):529-540. PubMed ID: 33538250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
    Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in All-Cause Mortality in the Decade Following Complex Coronary Revascularization.
    Hara H; Takahashi K; van Klaveren D; Wang R; Garg S; Ono M; Kawashima H; Gao C; Mack M; Holmes DR; Morice MC; Head SJ; Kappetein AP; Thuijs DJFM; Onuma Y; Noack T; Mohr FW; Davierwala PM; Serruys PW;
    J Am Coll Cardiol; 2020 Aug; 76(8):889-899. PubMed ID: 32819461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Percutaneous Coronary Intervention Versus Bypass Surgery for Patients With Left Main Disease: Results From the EXCEL Trial.
    Magnuson EA; Chinnakondepalli K; Vilain K; Serruys PW; Sabik JF; Kappetein AP; Stone GW; Cohen DJ;
    Circ Cardiovasc Interv; 2022 Jul; 15(7):e011981. PubMed ID: 35861797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease.
    Wang R; Serruys PW; Gao C; Hara H; Takahashi K; Ono M; Kawashima H; O'leary N; Holmes DR; Witkowski A; Curzen N; Burzotta F; James S; van Geuns RJ; Kappetein AP; Morel MA; Head SJ; Thuijs DJFM; Davierwala PM; O'Brien T; Fuster V; Garg S; Onuma Y
    Eur Heart J; 2021 Dec; 43(1):56-67. PubMed ID: 34405232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographical Difference of the Interaction of Sex With Treatment Strategy in Patients With Multivessel Disease and Left Main Disease: A Meta-Analysis From SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and BEST (Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) Randomized Controlled Trials.
    Sotomi Y; Onuma Y; Cavalcante R; Ahn JM; Lee CW; van Klaveren D; de Winter RJ; Wykrzykowska JJ; Farooq V; Morice MC; Steyerberg EW; Park SJ; Serruys PW
    Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28495897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.